GL1X · GenesisL1 explorer

MolNFT v1 · #144158 · protein

Novel modes of inhibition of wild-type IDH1: non-equivalent allosteric inhibition with CMPD3

6BKZ: “Novel modes of inhibition of wild-type IDH1: non-equivalent allosteric inhibition with CMPD3”. X-ray diffraction, 2 ligands (NAP, DWM). MolNFT v1 #144158 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6BKZ
Type
protein
Length
824 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
O75874
Ligands
NAP, DWM

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B—protein412—O75874

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains A, B
  • DWM · (7R)-1-[(4-fluorophenyl)methyl]-N-{3-[(1R)-1-hydroxyethyl]phenyl}-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6BKZ · Novel Modes of Inhibition of Wild-Type IDH1: Non-equivalent Allosteric Inhibition with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.